» Articles » PMID: 22274791

The Genetics of Psoriasis and Psoriatic Arthritis

Overview
Date 2012 Jan 26
PMID 22274791
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Genetic epidemiological studies have demonstrated a significant genetic basis to both psoriasis and psoriatic arthritis (PsA). Although candidate gene association studies had identified genes for disease susceptibility, recent genome-wide association studies have demonstrated robust associations both within and outside the major histocompatibility region on chromosome 6p. The susceptibility genes identified include HLA-C, IL13, IL4, TNFAIP3, IL23A, IL23R, IL28RA, REL, IFIH1, ERAP, TRAF3IP2, NFKBIA, TYK2, ZNF313, NOS2, FBXL19 and NFKBIA in subjects of European ethnicity and HLA-C, IL12B, LCE3D, ERAP1, TNIP1, PTTG1, CSMD1, GJB2, SERPINB8 and ZNF816A in subjects of Chinese ethnicity. These associations provide us with a model for the pathogenesis of psoriasis involving skin barrier function, innate and adaptive immunity. Gene-gene and gene-environmental interaction effects have also been demonstrated. However, loci identified to date do not fully account for the high heritability of psoriasis and PsA, and therefore many genetic as well as environmental factors and interaction effects remain to be determined. This article reviews the current status of genetic studies in psoriasis and PsA.

Citing Articles

Regulation of epidermal barrier function and pathogenesis of psoriasis by serine protease inhibitors.

Wang J, Li J, Zhou L, Hou H, Zhang K Front Immunol. 2024; 15:1498067.

PMID: 39737188 PMC: 11683130. DOI: 10.3389/fimmu.2024.1498067.


Psoriasis and Psoriatic Arthritis-Associated Genes, Cytokines, and Human Leukocyte Antigens.

Zalesak M, Danisovic L, Harsanyi S Medicina (Kaunas). 2024; 60(5).

PMID: 38792999 PMC: 11123327. DOI: 10.3390/medicina60050815.


FBXL19 promotes malignant behaviours by activating MAPK signalling and negatively correlates with prognosis in hepatocellular carcinoma.

Xun M, Wang J, Xie Q, Peng B, Li Z, Guo Z Heliyon. 2023; 9(11):e21771.

PMID: 38027627 PMC: 10651507. DOI: 10.1016/j.heliyon.2023.e21771.


A Transcriptome-Wide Analysis of Psoriasis: Identifying the Potential Causal Genes and Drug Candidates.

Jeong Y, Song J, Lee Y, Choi E, Won Y, Kim B Int J Mol Sci. 2023; 24(14).

PMID: 37511476 PMC: 10380797. DOI: 10.3390/ijms241411717.


Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?.

Curry P, Morris A, Barton A, Bluett J Pharmacogenomics J. 2022; 23(1):1-7.

PMID: 36243888 PMC: 9925377. DOI: 10.1038/s41397-022-00290-8.


References
1.
Nair R, Stuart P, Nistor I, Hiremagalore R, Chia N, Jenisch S . Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet. 2006; 78(5):827-851. PMC: 1474031. DOI: 10.1086/503821. View

2.
Hensen P, Windemuth C, Huffmeier U, Ruschendorf F, Stadelmann A, HOPPE V . Association scan of the novel psoriasis susceptibility region on chromosome 19: evidence for both susceptible and protective loci. Exp Dermatol. 2003; 12(4):490-6. DOI: 10.1034/j.1600-0625.2003.00040.x. View

3.
Gonzalez S, Martinez-Borra J, Torre-Alonso J, Del Rio J, Rodriguez Perez A, Brautbar C . The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum. 1999; 42(5):1010-6. DOI: 10.1002/1529-0131(199905)42:5<1010::AID-ANR21>3.0.CO;2-H. View

4.
. The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs. Am J Hum Genet. 2003; 73(2):430-7. PMC: 1180381. DOI: 10.1086/377159. View

5.
Rahman P, Inman R, Maksymowych W, Reeve J, Peddle L, Gladman D . Association of interleukin 23 receptor variants with psoriatic arthritis. J Rheumatol. 2008; 36(1):137-40. DOI: 10.3899/jrheum.080458. View